Civic AI
Procurement intelligence
Federal contract award
THRUST 7 - GENERATION OF A NOVEL ANTIBODY - ANTIBIOTIC CONJUGATE AS A COMBINATION THERAPY PLATFORM TO TREAT MELIODOSIS
MINISTRY OF DEFENCE · Department of Defense
- Value
- $5,630,591
- Start
- Jun 10, 2024
- End
- Jun 9, 2027
- Action date
- Jan 7, 2026
- PIID
- HDTRA124C0008
- Status
- active
- NAICS
- 541714 · RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)
- Place of performance
- —
- Award type
- DEFINITIVE CONTRACT
Description
THRUST 7 - GENERATION OF A NOVEL ANTIBODY - ANTIBIOTIC CONJUGATE AS A COMBINATION THERAPY PLATFORM TO TREAT MELIODOSIS
Need modifications, related awards, and vendor peers? Open the full award workspace.